Dual time-point 18F-FDG PET/CT to assess response to radiofrequency ablation of lung metastases

被引:5
|
作者
Lafuente, S. [1 ]
Fuster, D. [1 ]
Arguis, P. [2 ]
Granados, U. [1 ]
Perlaza, P. [1 ]
Paredes, P. [1 ]
Vollmer, I. [2 ]
Sanchez, M. [2 ]
Lomena, F. [1 ]
机构
[1] Hosp Clin Barcelona, Dept Nucl Med, Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Radiol, Barcelona, Spain
关键词
PET/CT; Delayed images; Radiofrequency; Lung metastases; Gastrointestinal cancer; FOLLOW-UP; PERCUTANEOUS RADIOFREQUENCY; PULMONARY NODULES; FDG-PET/CT; CT; TUMORS;
D O I
10.1016/j.remn.2015.12.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: To establish the usefulness of dual time-point PET/CT imaging in determining the response to radiofrequency ablation (RFA) of solitary lung metastases from gastrointestinal cancer. Materials and methods: This prospective study included 18 cases (3 female, 15 male, mean age 71 +/- 15 yrs) with solitary lung metastases from malignant digestive tract tumors candidates for RFA. PET/CT images 1 h after injection of 4.07 MBq/kg of F-18-FDG (standard images) were performed at baseline, 1 month, and 3 months after RFA. PET/CT images 2 h after injection centered in the thorax at 1 month after RFA were also performed (delayed images). A retention index (RI) of dual time-point images was calculated as follows: RI = (SUVmax delayed image - SUVmax standard image/SUVmax standard image) *100. Pathological confirmation of residual tumor by histology of the treated lesion was considered as local recurrence. A negative imaging follow-up was considered as complete response. Results: Local recurrence was found in 6/18 lesions, and complete response in the remaining 12. The mean percentage change in SUVmax at 1 month and at 3 months showed a sensitivity and specificity for PET/CT of 50% and 33%, and 67% and 92%, respectively. The RI at 1 month after RFA showed a sensitivity and specificity of 83% and 92%, respectively. Conclusions: Dual time point PET/CT can predict the outcome at one month after RFA in lung metastases from digestive tract cancers. The RI can be used to indicate the need for further procedures to rule out persistent tumor due to incomplete RFA. (C) 2015 Elsevier Espana, S.L.U. y SEMNIM. All rights reserved.
引用
收藏
页码:226 / 231
页数:6
相关论文
共 50 条
  • [31] Hepatoid adenocarcinoma of the stomach: dual-time-point 18F-FDG PET/CT findings
    Sun, Xiaorong
    Li, Yuhui
    Dong, Min
    Li, Wenwu
    Xing, Ligang
    JAPANESE JOURNAL OF RADIOLOGY, 2014, 32 (12) : 721 - 724
  • [32] Dual-Time-Point PET/CT with 18F-FDG for Differentiation of Malignant and Benign Lesions
    Ferreira, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S768 - S769
  • [33] Evaluation of dual time point imaging 18F-FDG PET/CT in the diagnosis of gastric disease
    Cui, Jing
    Gao, Yongju
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [34] Hepatoid adenocarcinoma of the stomach: dual-time-point 18F-FDG PET/CT findings
    Xiaorong Sun
    Yuhui Li
    Min Dong
    Wenwu Li
    Ligang Xing
    Japanese Journal of Radiology, 2014, 32 : 721 - 724
  • [35] A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases
    Khandani, Amir H.
    Calvo, Benjamin F.
    O'Neil, Bert H.
    Jorgenson, Jennifer
    Mauro, Matthew A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 189 (05) : 1199 - 1202
  • [36] Dual time point 18F-FDG PET for the evaluation of pulmonary nodules
    Matthies, A
    Hickeson, M
    Cuchiara, A
    Alavi, A
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (07) : 871 - 875
  • [37] Simple Pulmonary Eosinophilia Mimicking Lung Metastases on 18F-FDG PET/CT
    Yang, Lan
    Dong, Ziqian
    Wei, Lingge
    Chen, Feilong
    Xie, Peng
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : 884 - 885
  • [38] 18F-FDG PET and 18F-FDG PET/CT for Assessing Response to Therapy in Esophageal Cancer
    Krause, Bernd J.
    Herrmann, Ken
    Wieder, Hinrich
    zum Bueschenfelde, Christian Meyer
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 : 89S - 96S
  • [39] The metabolic change of dual-time-point 18F-FDG PET/CT in patients with suspected of having lung cancer
    Lee, J.
    Jang, S.
    Lee, J.
    Kim, E.
    Jeong, H.
    Rho, J.
    Cho, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S637 - S637
  • [40] Evaluation of Dual-Time-Point 18F-FDG PET for Staging in Patients with Lung Cancer
    Uesaka, Daisuke
    Demura, Yoshiki
    Ishizaki, Takeshi
    Ameshima, Shingo
    Miyamori, Isamu
    Sasaki, Masato
    Fujibayashi, Yasuhisa
    Okazawa, Hidehiko
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (10) : 1606 - 1612